⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL484143 | 0.94 | — | — | |
| SCHEMBL7052459 | 0.94 | — | — | |
| SCHEMBL28278920 | 0.89 | — | — | |
| Ammonia Solution, Strong SCHEMBL29078776 | 0.89 | — | — | |
| SCHEMBL6051713 | 0.68 | — | — | |
| SCHEMBL6812435 | 0.68 | — | — | |
| SCHEMBL17921336 | 0.65 | — | — | |
| SCHEMBL18681 | 0.60 | — | — | |
| SCHEMBL667648 | 0.60 | — | — | |
| SCHEMBL3994247 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114044753-A | Small molecular compound with anti-tumor metastasis function and preparation method thereof | 广州市朝利良生物科技有限公司 | 2022-02-15 | — | — | CN | claimed |
| EP-0128839-B1 | LABELLED STEROIDS, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES, THEIR USE IN THE LOCALIZATION OF THE GLUCOCORTICOID RECEPTORS AND IN THE DOSAGE OF THE NUMBER OF BINDING SITES | ROUSSEL-UCLAF (FR) | 1989-05-17 | — | — | EP | claimed |
| US-4664850-A | Novel radioactive steroids | ROUSSEL UCLAF (FR) | 1987-05-12 | — | — | US | claimed |
| EP-4656240-A1 | NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER | Novartis AG (CH) | 2025-12-03 | — | — | EP | disclosed |
| US-12459893-B2 | Indole-ynone mediated benzoannulation process for the preparation of carbazoles, carbazomycin A, calothrixin B and staurosporinone | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2025-11-04 | — | — | US | disclosed |
| EP-4436662-B1 | NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER | NOVARTIS AG (CH) | 2025-09-17 | — | — | EP | disclosed |
| US-20250270210-A1 | BCL-2 Inhibitor | BEIGENE, LTD. (KY) | 2025-08-28 | — | — | US | disclosed |
| US-20250214989-A1 | NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER | NOVARTIS AG (CH) | 2025-07-03 | — | — | US | disclosed |
| US-12286430-B2 | Bcl-2 inhibitor | BEIGENE, LTD. (KY) | 2025-04-29 | — | — | US | disclosed |
| US-20250066584-A1 | PHOTOINITIATORS, COMPOSITIONS, AND METHODS OF FORMING AN OBJECT | QUADRATIC 3D, INC. | 2025-02-27 | — | — | US | disclosed |
| EP-4508492-A1 | PHOTOINITIATORS, COMPOSITIONS, AND METHODS OF FORMING AN OBJECT | Quadratic 3D, Inc. (US) | 2025-02-19 | — | — | EP | disclosed |
| US-4086249-A | Tetramethyl chromanyl pentane amide | HOFFMANN-LA ROCHE INC. (US) | 1978-04-25 | — | — | US | disclosed |
| US-4076739-A | Synthesis of vitamin E | HOFFMANN-LA ROCHE INC. (US) | 1978-02-28 | — | — | US | disclosed |
| US-4045475-A | Optically active alcohols and lower esters thereof | HOFFMANN-LA ROCHE INC. (US) | 1977-08-30 | — | — | US | disclosed |
| US-4029678-A | Asymmetric synthesis | HOFFMANN-LA ROCHE INC. (US) | 1977-06-14 | — | — | US | disclosed |
| US-4016178-A | Synthesis of vitamin E | HOFFMANN-LA ROCHE INC. (US) | 1977-04-05 | — | — | US | disclosed |
| US-4012391-A | 11β-Alkyl-2-azaestratrienes and intermediates | G. D. SEARLE & CO. (US) | 1977-03-15 | — | — | US | disclosed |
| US-4000169-A | ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 1976-12-28 | — | — | US | disclosed |
| US-3965143-A | 16-Oxygenated prostanoic acid derivatives | G. D. SEARLE & CO. (US) | 1976-06-22 | — | — | US | disclosed |
| US-3959322-A | Synthesis of 13-alkyl-gon-4-ones | Smith, Herchel (US) | 1976-05-25 | — | — | US | disclosed |